A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)

S. Maruyama, T. Okumoto, K. Kawasaki, Hideo Ino, Y. Kanaya, J. Otani, N. Yokoyama, M. Soda

Research output: Contribution to journalArticle

Abstract

A 52-year-old woman complaining of breast tumor was diagnosed as having advanced breast cancer (T4bN1M1-Stage IV), with metastasis of multiple organs (lung, liver, mediastinal and unilateral axillary lymph nodes) after which she underwent tumorectomy. Postoperative adjuvant therapy was performed using combined chemoendocrine therapy (CAF + 5'-DFUR + MPA). Following the endocrine therapy, the metastatic lesions of the liver and lung had disappeared. The adverse effects were not remarkable. Complete remission was continued for 2 years and 3 months, and the patient enjoyed a favorable quality of life.

Original languageEnglish
Pages (from-to)2235-2238
Number of pages4
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume27
Issue number14
Publication statusPublished - Dec 2000
Externally publishedYes

Fingerprint

Medroxyprogesterone Acetate
Fluorouracil
Doxorubicin
Cyclophosphamide
Breast Neoplasms
Neoplasm Metastasis
Lung
Liver
Therapeutics
Lymph Nodes
Quality of Life
doxifluridine

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate). / Maruyama, S.; Okumoto, T.; Kawasaki, K.; Ino, Hideo; Kanaya, Y.; Otani, J.; Yokoyama, N.; Soda, M.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 27, No. 14, 12.2000, p. 2235-2238.

Research output: Contribution to journalArticle

@article{05c9e2658bba4d84bc30ddae9f1de0e5,
title = "A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)",
abstract = "A 52-year-old woman complaining of breast tumor was diagnosed as having advanced breast cancer (T4bN1M1-Stage IV), with metastasis of multiple organs (lung, liver, mediastinal and unilateral axillary lymph nodes) after which she underwent tumorectomy. Postoperative adjuvant therapy was performed using combined chemoendocrine therapy (CAF + 5'-DFUR + MPA). Following the endocrine therapy, the metastatic lesions of the liver and lung had disappeared. The adverse effects were not remarkable. Complete remission was continued for 2 years and 3 months, and the patient enjoyed a favorable quality of life.",
author = "S. Maruyama and T. Okumoto and K. Kawasaki and Hideo Ino and Y. Kanaya and J. Otani and N. Yokoyama and M. Soda",
year = "2000",
month = "12",
language = "English",
volume = "27",
pages = "2235--2238",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "14",

}

TY - JOUR

T1 - A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)

AU - Maruyama, S.

AU - Okumoto, T.

AU - Kawasaki, K.

AU - Ino, Hideo

AU - Kanaya, Y.

AU - Otani, J.

AU - Yokoyama, N.

AU - Soda, M.

PY - 2000/12

Y1 - 2000/12

N2 - A 52-year-old woman complaining of breast tumor was diagnosed as having advanced breast cancer (T4bN1M1-Stage IV), with metastasis of multiple organs (lung, liver, mediastinal and unilateral axillary lymph nodes) after which she underwent tumorectomy. Postoperative adjuvant therapy was performed using combined chemoendocrine therapy (CAF + 5'-DFUR + MPA). Following the endocrine therapy, the metastatic lesions of the liver and lung had disappeared. The adverse effects were not remarkable. Complete remission was continued for 2 years and 3 months, and the patient enjoyed a favorable quality of life.

AB - A 52-year-old woman complaining of breast tumor was diagnosed as having advanced breast cancer (T4bN1M1-Stage IV), with metastasis of multiple organs (lung, liver, mediastinal and unilateral axillary lymph nodes) after which she underwent tumorectomy. Postoperative adjuvant therapy was performed using combined chemoendocrine therapy (CAF + 5'-DFUR + MPA). Following the endocrine therapy, the metastatic lesions of the liver and lung had disappeared. The adverse effects were not remarkable. Complete remission was continued for 2 years and 3 months, and the patient enjoyed a favorable quality of life.

UR - http://www.scopus.com/inward/record.url?scp=0034565809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034565809&partnerID=8YFLogxK

M3 - Article

C2 - 11142168

AN - SCOPUS:0034565809

VL - 27

SP - 2235

EP - 2238

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 14

ER -